Poly(ADP-Ribose) polymerase inhibition down-regulates expression of metastasis-related genes in CT26 colon carcinoma cells

Pathobiology

Volumn 76, Issue 3, 2009, Pages 108-116

  Li, Ming ^a   Threadgill, Michael D ^a,b   Wang, Yalan ^a   Cai, Li ^a   Lin, Xiao ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b University of Bath   (United Kingdom)

Author keywords

Cell adhesion; Colorectal cancer; Metastasis; Nuclear factor B; PARP inhibitors; Poly(ADP ribose) polymerase

Indexed keywords

5 AMINOISOQUINOLIN 1(H) ONE HYDROCHLORIDE; BETA1 INTEGRIN; CHLORIDE; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CELL ADHESION; CELL MIGRATION; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GENE; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; NEOPLASM INVASIVENESS; NF-KAPPA B; POLY(ADP-RIBOSE) POLYMERASES;

EID: 67649592959     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209388     Document Type: Article

References (54)

1. Woon ECY, Threadgill MD: Poly(ADP-ribose)polymerase inhibition - where now? Curr Med Chem 2005;12:2373-2392.
2. Diefenbach J, Bürkle A: Introduction to poly(ADP-ribose) metabolism. Cell Mol Life Sci 2005;62:721-730.
3. Fong PC, Spicer J, Reade S, Reid A, Vidal L, Schellens JH, Tutt A, Harris PA, Kaye S, De Bono JS: Phase I pharmacokinetic (PK) and pharmacodynamic (PD) evaluation of a small molecule inhibitor of poly ADP-ribose polymerase (PARP), KU-0059436 (Ku) in patients (p) with advanced tumours. J Clin Oncol 2006;24:126S.
4. Plummer R, Lorigan P, Evans J, Steven N, Middleton M, Wilson R, Snow K, Dewji R, Calvert H:First and final report of a phase II study of the poly(ADP-ribose) polymerase (PARP) inhibitor, AG014699, in combination with temozolomide (TMZ) in patients with metastatic malignant melanoma (MM). J Clin Oncol 2006;24:456S.
5. Plummer R, Middleton M, Wilson R, Evans J, Jones C, Olson A, Boddy A, Curtin N, Kaufman R, Harris A, Johnston P, Newell H: Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide. Clin Cancer Res 2005;11:9099S.
6. Ratnam K, Low JA: Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology. Clin Cancer Res 2007;13:1383-1388.
7. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP: Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005;434:917-921.
8. Virág L, Szabó C: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002;54:375-429.
9. McDonald MC, Mota-Filipe H, Wright JA, Abdelrahman M, Threadgill MD, Thompson AS, Thiemermann C: Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock. Br J Pharmacol 2000;130:843-850.
10. Wayman N, McDonald MC, Thompson AS, Threadgill MD, Thiemermann C: 5-Aminoisoquinolinone, a water-soluble potent inhibitor of poly(adenosine 5'-diphosphate ribose) polymerase, reduces myocardial infarct size. Eur J Pharmacol 2001;430:93-100.
11. Chatterjee PK, Chatterjee BE, Pedersen H, Sivarajah A, McDonald MC, Mota-Filipe H, Brown PA, Stewart KN, Cuzzocrea S, Threadgill MD, Thiemermann C: 5-Aminoisoquinolinone reduces renal injury and dysfunction caused by ischemia/reperfusion. Kidney Int 2004;65:499-509.
12. Di Paola R, Genovese T, Caputi AP, Threadgill MD, Thiemermann C, Cuzzocrea S: Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion. Eur J Pharmacol 2004;492:203-210.
13. Mota-Filipe H, Sepodes B, McDonald MC, Cuzzocrea S, Pinto R, Thiemermann C: The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat. Med Sci Monit 2002;8:444-453.
14. Cuzzocrea S, Mazzon E, Di Paola R, Genovese T, Patel NS, Muia C, Threadgill MD, De Sarro A, Thiemermann C: 5-Aminoisoquinolinone reduces colon injury by experimental colitis. Naunyn Schmiedebergs Arch Pharmacol 2004;370:464-473.
15. Genovese T, Mazzon E, Muià C, Patel NS, Threadgill MD, Bramanti P, De Sarro A, Thiemermann C, Cuzzocrea S: Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma. J Pharmacol Exp Ther 2005;312:449-457.
16. Cuzzocrea S, McDonald MC, Mazzon E, Dugo L, Serraino I, Threadgill MD, Caputi AP, Thiemermann C: Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly(ADP-ribose) polymerase, in a rodent model of lung injury. Biochem Pharmacol 2002;63:293-304.
17. Sanchez-Fidalgo S, Villegas I, Martin A, Sanchez-Hidalgo M, Alarcon de la Lastra C: PARP inhibition reduces acute colonic inflammation in rats. Eur J Pharmacol 2007;563:216-223.
18. Di Paola R, Mazzon E, Muià C, Terrana D, Greco S, Britti D, Santori D, Oteri G, Cordasco G, Cuzzocrea S: 5-Aminoisoquinolin-1(2H)-one, a water-soluble poly (ADP-ribose) polymerase (PARP) inhibitor reduces the evolution of experimental periodontitis in rats. J Clin Periodontol 2007;34:95-102.
19. Koh SH, Chang DI, Kim HT, Kim J, Kim MH, Kyung SK, Bae I, Kim H, Dong WK, Seung HK: Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloprotein-ase-9 level in plasma and brain of ischemic stroke model. Toxicology 2005;214:131-139.
20. Hassa PO, Hottiger MO: A role of poly (ADP-ribose) polymerase in NF-κB transcriptional activation. Biol Chem 1999;380:953-959.
21. Hassa PO, Buerki C, Lombardi C, Imhof R Hottiger MO: Transcriptional coactivation of nuclear factor- κB-dependent gene expression by p300 is regulated by poly (ADP)-ribose polymerase-1. J Biol Chem 2003;278: 45145-45153.
22. Veres B, Radnai B, Gallyas F Jr, Varbiro G, Berente Z, Osz E, Sumegi B: Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice. J Pharmacol Exp Ther 2004;310:247-255.
23. Nakajima H, Nagaso H, Kakui N, Ishikawa M, Hiranuma T, Hoshiko S: Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-κB-dependent gene expression in primary cultured mouse glial cells. J Biol Chem 2004;279: 42774-42786.
24. Tentori L, Leonetti C, Scarsella M , Muzi A, Mazzon E, Vergati M, Forini O, Lapidus R Xu W, Dorio AS, Zhang J, Cuzzocrea S: Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma. FASEB J 2006;20:1709-1711.
25. Kang YH, Yi MJ, Kim MJ, Park MT, Bae S, Kang CM, Cho CK, Park IC, Park MJ, Rhee CH, Hong SI, Chung HY: Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res 2004;64:8960-8967.
26. Trofimova I, Dimtchev A, Jung M, Rosenthal D, Smulson M, Dritschilo A, Soldatenkov V: Gene therapy for prostate cancer by targeting poly(ADP-ribose) polymerase. Cancer Res 2002;62:6879-6883.
27. Martin-Oliva D, Aguilar-Quesada R, O'Valle F, Muñoz-Gámez JA, Martínez-Romero R García del Moral R, Ruiz de Almodóvar JM, Villuendas R, Piris MA, Oliver FJ: Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. Cancer Res 2006;66: 5744-5756.
28. Rajesh M, Mukhopadhyay P, Godlewski G, Bátkai S, Haskó G, Liaudet L, Pacher P: Poly(ADP-ribose)polymerase inhibition decreases angiogenesis. Biochem Biophys Res Commun 2006;350:1056-1062.
29. Hao LX, Wang YL, Cai L, Li YY: Inhibitory effect of 5-aminoisoquinolinone on PARP activity in colon carcinoma cell line HT29. Ai Zheng 2007;26:566-571.
30. Watson CY, Whish WJD, Threadgill MD: Synthesis of 3-substituted benzamides and 5-substituted isoquinolin-1(2H)-ones and preliminary evaluation as inhibitors of poly(ADP-ribose)polymerase (PARP). Bioorg Med Chem 1998;6:721-734.
31. Szabó G, Bährle S, Stumpf N, Sonnenberg K, Szabó É, Pacher P, Csont T, Schulz R, Dengler TJ, Liaudet L, Jagtap PG, Southan GJ: Poly(ADP-ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res 2002;90:100-106.
32. von Lampe B, Stallmach A, Riecken EO: Altered glycosylation of integrin adhesion molecules in colorectal cancer cells and decreased adhesion to the extracellular matrix. Gut 1993;34:829-836.
33. Zeng ZS, Cohen AM, Guillem JG: Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 1999;20:749-755.
34. Odero-Marah VA, Khalkhali-Ellis Z, Chunthapong J, Amir S, Seftor RE, Seftor EA, Hendrix MJ: Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells. Cancer Biol Ther 2003;2:398-403.
35. Wick W, Wagner S, Kerkau S, Dichgans J, Tonn JC, Weller M:BCL-2 promotes migration and invasiveness of human glioma cells. FEBS Lett 1998;440:419-424.
36. Lee HK, Lee JH, Kim M, Kariya Y, Miyazaki K, Kim EK: Insulin-like growth factor-1 induces migration and expression of laminin-5 in cultured human corneal epithelial cells. Invest Ophthalmol Vis Sci 2006;47:873-882.
37. Quesada A, Barbacid M, Mira E, Fernádez-Resa P, Máquez G, Aracil M: Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases. Clin Exp Metastasis 1997;15:26-32.
38. Lee CH, Jeon YT, Kim SH, Song YS: NF-κB as a potential molecular target for cancer therapy. Biofactors 2007;29:19-35.
39. Felding-Habermann B: Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 2003;20:203-213.
40. Deryugina EI, Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006;25:9-34.
41. Curran S, Murray GI: Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000;36:1621-1630.
42. Nagakawa Y, Aoki T, Tsuchida A, Koyanagi Y: Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer. Pancreas 2002;24:169-178.
43. 1 integrin-dependent mechanism. J Immunol 2003;170:795-804.
44. Marin-Castaño ME, Elliot SJ, Potier M, Karl M, Striker LJ, Striker GE, Csaky KG, Cousins SW: Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2003;44:50-59.
45. Hozumi A, Nishimura Y, Nishiuma T, Kotani Y, Yokoyama M: Induction of MMP-9 in normal human bronchial epithelial cells by TNF-α via NF-κB-mediated pathway. Am J Physiol Lung Cell Mol Physiol 2001;281: L1444-L1452.
46. Cheng JC-H, Chou CH, Kuo ML, Hsieh CY Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-κB signal transduction pathway. Oncogene 2006;25: 7009-7018.
47. Zheng L, Szabó C, Kern TS: Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-κB diabetes 2004;53:2960-2967.
48. Pétrilli V, Herceg Z, Hassa PO, Patel NS, Di Paola R, Cortes U, Dugo L, Filipe HM, Thiemermann C, Hottiger MO, Cuzzocrea S, Wang ZQ: Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice. J Clin Invest 2004;114: 1072-1081.
49. Kauppinen TM, Swanson RA: Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death. J Immunol 2005;174:2288-2296.
50. Hassa PO, Haenni SS, Buerki C, Meier NI, Lane WS, Owen H, Gersbach M, Imhof R, Hottiger MO: Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-κB-dependent transcription. J Biol Chem 2005;280:40450-40464.
51. Hauschildt S, Scheipers P, Bessler W, Schwarz K, Ullmer A, Flad HD, Heine H: Role of ADP-ribosylation in activated monocytes/ macrophages. Adv Exp Med Biol 1997;419: 249-252.
52. Genovese T, Mazzon E, Di Paola R, Muià C, Threadgill MD, Caputi AP, Thiemermann C, Cuzzocrea S: Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury. J Pharmacol Exp Ther 2005;313:529-538.
53. Geng L, Ali SA, Marshall JF, Mackay CL, Hart IR, Delcommence M, Streuli CH, Rees RC: Fibronectin is chemotactic for CT 26 colon carcinoma cells: sub-lines selected for increased chemotaxis to fibronectin display decreased tumorigenicity and lung colonization. Clin Exp Metastasis 1998;16:683-691.
54. Harnacke K, Kruhøffer M, Ørntoft TF, Hass R: Down-modulation of poly(ADP-ribose) polymerase-1 (PARP-1) in human TUR leukemia cells restores transcriptional responsiveness for differentiation and cell cycle arrest. Eur J Cell Biol 2005;84:885-896.